Management of Neuropsychiatric Systemic Lupus Erythematosus: Current Approaches and Future Perspectives

Drugs
César Magro-ChecaGerda M Steup-Beekman

Abstract

Neuropsychiatric systemic lupus erythematosus (NPSLE) is a generic definition referring to a series of neurological and psychiatric symptoms directly related to systemic lupus erythematosus (SLE). NPSLE includes heterogeneous and rare neuropsychiatric (NP) manifestations involving both the central and peripheral nervous system. Due to the lack of a gold standard, the attribution of NP symptoms to SLE represents a clinical challenge that obligates the strict exclusion of any other potential cause. In the acute setting, management of these patients does not differ from other non-SLE subjects presenting with the same NP manifestation. Afterwards, an individualized therapeutic strategy, depending on the presenting manifestation and severity of symptoms, must be started. Clinical trials in NPSLE are scarce and most of the data are extracted from case series and case reports. High-dose glucocorticoids and intravenous cyclophosphamide remain the cornerstone for patients with severe symptoms that are thought to reflect inflammation or an underlying autoimmune process. Rituximab, intravenous immunoglobulins, or plasmapheresis may be used if response is not achieved. When patients present with mild to moderate NP manifestations, or when ...Continue Reading

References

Jan 1, 1975·Arthritis and Rheumatism·E GinzlerD Kaplan
Sep 1, 1992·Seizure : the Journal of the British Epilepsy Association·G J LuijckxB C Takx-Kohlen
Nov 1, 1992·The American Journal of Medicine·M PetriM C Hochberg
Dec 1, 1991·The Quarterly Journal of Medicine·D T BoumpasJ E Balow
Mar 6, 1986·The New England Journal of Medicine·H A AustinJ L Decker
Jan 18, 1973·The New England Journal of Medicine·E SharonH S Diamond
Sep 1, 1983·Medicine·M H MillerD W Killinger
Jan 1, 1994·Drugs·B BannwarthT Schaeverbeke
Feb 1, 1996·Lupus·A R Cabral, D Alarcón-Segovia
Jan 1, 1996·Scandinavian Journal of Rheumatology·M Petri
Jun 1, 1996·Lupus·D J Wallace
Aug 16, 2000·Arthritis and Rheumatism·A Zonana-NacachM Petri
Sep 8, 2001·The New England Journal of Medicine·M D Kazatchkine, S V Kaveri
Jun 4, 2002·Best Practice & Research. Clinical Rheumatology·David Hermosillo-Romo, Robin L Brey
Oct 16, 2002·Journal of Clinical Apheresis·Bruce C McLeod
Nov 21, 2002·Pharmacology & Therapeutics·Heike SchäckeKhusru Asadullah
Jan 22, 2003·Drugs·Fayez F HejailiWilliam F Clark
Jul 18, 2003·The American Journal of Medicine·Chi Chiu MokRaymond W S Wong
Aug 16, 2003·Therapeutic Apheresis and Dialysis : Official Peer-reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy·Leo J McCarthy
Aug 16, 2003·Therapeutic Apheresis and Dialysis : Official Peer-reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy·C Michael Neuwelt
Dec 19, 2003·The New England Journal of Medicine·Mary J RomanJane E Salmon
Feb 6, 2004·JAMA : the Journal of the American Medical Association·Steven R LevineUNKNOWN APASS Investigators

❮ Previous
Next ❯

Citations

Aug 26, 2016·PLoS Neglected Tropical Diseases·Zachary A KlaseRobert Malone
Jul 12, 2017·Journal of Child and Adolescent Psychopharmacology·Ellen J SpartzJennifer Frankovich
Mar 20, 2018·Journal of the International Neuropsychological Society : JINS·Arantzazu ZabalaRafael Segarra
Jul 25, 2018·Expert Opinion on Biological Therapy·Zdenka Hruskova, Vladimir Tesar
Jun 28, 2018·Modern Rheumatology·Kenji Oku, Tatsuya Atsumi
Mar 27, 2019·JAAPA : Official Journal of the American Academy of Physician Assistants·Morgan Walgren
Jan 26, 2018·Nihon Rinshō Men'eki Gakkai kaishi = Japanese journal of clinical immunology·Kunihiro Ichinose
Jul 10, 2020·The Tohoku Journal of Experimental Medicine·Jumpei TemmokuKiyoshi Migita
Mar 16, 2019·Frontiers in Immunology·Yuting JiangXuefeng Wang
Nov 9, 2017·International Journal of Geriatric Psychiatry·Omer GendelmanDaniela Amital
Jun 17, 2020·Frontiers in Medicine·Marlene PlüßPeter Korsten
May 28, 2020·Immunological Medicine·Yuichiro Fujieda
Nov 14, 2019·Seminars in Immunology·Douwe J DijkstraLeendert A Trouw
Feb 21, 2021·Autoimmunity Reviews·Irene Carrión-BarberàJordi Monfort
Feb 20, 2021·Brain, Behavior, and Immunity·Kim BrowneTrine N Jorgensen
Mar 22, 2020·Physiological Research·V BalajkovaL Senolt
Jun 2, 2021·Journal of Neuroimmunology·Xiaoyue QiaoHuan Dou
Jun 23, 2021·BMJ Case Reports·Narueporn LikhitweerawongOrawan Louthrenoo
Jul 7, 2021·European Journal of Internal Medicine·Hao ChengHong-Yan Wen
Oct 8, 2021·Seminars in Neurology·Kristin Galetta, Shamik Bhattacharyya

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.

Related Papers

Expert Review of Clinical Pharmacology
Shaye KivityYehuda Shoenfeld
Nature Reviews. Rheumatology
George K Bertsias, Dimitrios T Boumpas
Current Neuropharmacology
Alexandra Popescu, Amy H Kao
© 2021 Meta ULC. All rights reserved